Biontech Marburg - Pro­duc­tion of the Corona vaccine

Wearing full-body protective suits, laboratory assistants from the company Biontech simulate the final steps in the production of the Corona vaccine on a bioreactor in a clean room at the new production site in Marburg. According to earlier information from the company, 250 million doses of the vaccine from Biontech and its US partner Pfizer are to be produced in Marburg in the first half of 2021. Once the Marburg plant is fully operational, the company plans to produce 750 million doses of the COVID-19 vaccine there annually.